The Global Home Healthcare Market is Expected to Grow at a CAGR of 7.8% During the Forecast Period (2018-2025)

DUBLIN, Nov 8, 2018 /PRNewswire/ --

The "Home Healthcare Market Analysis Report By Component (Equipment (Diagnostic, Therapeutic, Mobility Assist), Services (Rehabilitation, Infusion Therapy, Respiratory Therapy Services)) And Segment Forecasts 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

The global home healthcare market size is anticipated to reach USD 517.23 billion by 2025, progressing at a CAGR of 7.8% during the forecast period.

Demand for home healthcare services is rising owing to benefits such as improved patient outcome, long term care, cost efficiency, elimination of unnecessary hospitalization, and patient preferred settings.

Growing incidence of target diseases such as dementia and Alzheimer's as well as orthopedic diseases is expected to stoke the growth of the market. Increasing treatment cost is one of the prime concerns for governments and healthcare organizations and they are, therefore, striving to curb healthcare costs.

Increasing disposable income is enabling patients to take up home healthcare services. In addition, internet is responsible for providing integrated technology, which bridges treatment options. Setting up of hospitals and healthcare centers require huge capital investment, this is leading to merger and acquisition of market players in order to capitalize opportunities and boost market growth.

For instance, National Nursing & Rehab acquired Home Health Services in 2014 in order to expand their service in Texas metropolitan areas. Insurance plans have been formulated by government to cater long term needs of the patients. For instance, about 40% of revenues generated for Homecare Medical Equipment (HME) is covered by Medicare and Medicaid.

Market Dynamics

Drivers

• Home Healthcare as a Cost-Effective Alternative
• Growing Number of Home Health and Personal Care Aides
• Growing Geriatric Population
• Hospital Solution Providers Penetrating the Home Healthcare Market
• Growing Prevalence of Target Diseases, Especially Alzheimer's and Other Dementias

Restraints

• Complicated Reimbursement Framework and Reimbursement Cuts
• Lower Remunerations

Key Findings

• Services dominated the component segment in 2016. Rehabilitation services accounted for more than 59.0% of the overall home healthcare services market in 2016.
• The therapeutic equipment segment dominated the home healthcare equipment market in 2016. Growing prevalence of respiratory & urological disorders coupled with introduction of technologically advanced products suitable for home healthcare, such as portable dialysis machines, is one of the key growth stimulants.
• North America dominated the home healthcare market in 2016. This can be attributed to presence of advanced medical infrastructure, high awareness among patients, and comparatively higher healthcare expenditure in the region.
• Some of the key players in this vertical are Almost Family Inc.; B. Braun Melsungen AG; Abbott Laboratories; Sunrise Medical; 3M Healthcare; Baxter International Inc.; Medtronic; Cardinal Health Inc.; F. Hoffmann-La Roche AG; and Air Liquide.

Topics Covered

Chapter 1 Report Scope
1.1 Segment Market Scope
1.2 Regional Scope

Chapter 2 Methodology
2.1 Research Methodology
2.2 Information or Data Analysis
2.3 Market Formulation & Validation
2.4 Region Wise Market Calculation
2.5 Region Based Segment Share Calculation
2.6 Model Details
2.7 List of Secondary Sources
2.8 List of Primary Sources
2.9 List of Abbreviations

Chapter 3 Objectives
3.1 Objective - 1
3.2 Objective - 2
3.3 Objective - 3
3.4 Objective - 4

Chapter 4 Executive Summary

Chapter 5 Market Definition
5.1 Therapeutic
5.2 Diagnostics Home Healthcare Equipment

Chapter 6 Industry Outlook
6.1 Market Segmentation
6.2 Business Segment Trends
6.3 Market Variable Analysis
6.3.1 Market driver analysis
6.3.1.1 Home healthcare as a cost-effective alternative
6.3.1.2 Growing number of home health and personal care aides
6.3.1.3 Growing geriatric population
6.3.1.4 Hospital solution providers penetrating the home healthcare market
6.3.1.5 Growing prevalence of target diseases, especially Alzheimer's and other dementias
6.3.2 Market restraint analysis
6.3.2.1 Complicated reimbursement framework and reimbursement cuts
6.3.2.2 Lower remunerations
6.4 Penetration & Growth Prospect Mapping
6.5 Business Environment Analysis tools

Chapter 7 Regulatory & Political Forces
7.1 North America
7.2 Europe
7.3 Asia

Chapter 8 Competitive & Vendor Landscape
8.1 Participant Categorization

Chapter 9 Segment Analysis
9.1 Home Healthcare Market: Component Movement Analysis
9.2 Equipment
9.3 Services

Chapter 10 Regional Outlook
10.1 Home Healthcare Market Share by Region, 2016 & 2025
10.2 North America
10.3 U.S.
10.4 Canada
10.5 Europe
10.6 U.K.
10.7 Germany
10.8 Italy
10.9 Spain
10.10 Sweden
10.11 France
10.12 Russia
10.13 Netherlands
10.14 Asia Pacific
10.15 Japan
10.16 China
10.17 India
10.18 Australia
10.19 Singapore
10.21 Malaysia
10.23 Thailand
10.24 Philippines
10.25 Korea
10.26 Latin America
10.27 Brazil
10.28 Mexico
10.29 Argentina
10.30 MEA
10.31 South Africa
10.32 Saudi Arabia
10.33 Oman
10.34 UAE
10.35 Egypt

Chapter 11 Company Profiles
11.1 Strategic Framework
11.2 Company Profiles
11.2.1 Almost Family Inc.
11.2.2 B. Braun Melsungen AG
11.2.3 Abbott
11.2.4 Sunrise Medical.
11.2.5 3M Healthcare
11.2.6 Baxter International Inc.
11.2.7 Medtronic
11.2.8 Cardinal Health Inc.
11.2.9 F. Hoffmann-La Roche AG
11.2.10 Air Liquide
11.2.11 Amedisys, Inc.
11.2.12 NxStage Medical, Inc.
11.2.13 Arkray, Inc.
11.2.14 Odyssey Healthcare, Inc.
11.2.15 Becton, Dickinson and Company
11.2.16 National HealthCare Corporation
11.2.17 Omron Healthcare, Inc.
11.2.18 Drive DeVilbiss Healthcare
11.2.19 Chubb Fire & Security Pty Ltd
11.2.20 GE Healthcare
11.2.21 Medline Industries, Inc.
11.2.22 Koninklijke Philips N.V.
11.2.23 GF HEALTH PRODUCTS, INC.
11.2.24 Hill-Rom, Inc.
11.2.25 Gentiva Health Services, Inc.
11.2.26 Johnson & Johnson Services, Inc.
11.2.27 Linde Healthcare
11.2.28 Acelity.
11.2.29 Vygon
11.2.30 Teleflex, Inc.
11.2.31 Moog, Inc.
11.2.32 Intersurgical Ltd.
11.2.33 Fresenius Kabi AG.
11.2.34 Bayer HealthCare
11.2.35 GF Health Products, Inc.
11.2.36 Medco Home Healthcare, Inc.
11.2.37 Arcadia

Chapter 12 KOL Commentary

Chapter 13 Recommendations

For more information about this report visit https://www.researchandmarkets.com/research/czx8pk/the_global_home?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets